RESUMO
Two groups of laying hens (each n=12) were administered 10 mg/kg enrofloxacin (ENRO) (group A) or 26.6 mg/kg flumequine (FLU) (group B) by gastric catheter daily for five consecutive days. A third group (n=6) was untreated controls. Eggs were collected from day one of treatment and up to 30 days after withdrawal of the drug. Egg white and yolk from each egg were separated, and ENRO, its metabolite ciprofloxacin (CIP) and FLU residues were analysed by a high-performance liquid chromatography method with fluorescence detection. The sum of ENRO and CIP was detectable in egg white on the first day of treatment in high-level concentrations (2007.7 µg/kg) and remained steady during administration. In egg yolk, residues were detectable at day one in lower concentrations (324.4 µg/kg), increasing to the end of treatment. After treatment, these residues decreased and were detectable up to day 8 in egg white, and day 10 in yolk. FLU residues during drug administration in white were detectable in high concentrations from day one to five (6788.4-6525.9 µg/kg), and in yolk, concentrations were lower during administration (629.6-853.9 µg/kg). After drug withdrawal, FLU residues remained longer in egg white (30 days) than in yolk (26 days). For both drugs, differences of concentrations between matrices were significant.
Assuntos
Galinhas/metabolismo , Resíduos de Drogas/análise , Ovos/análise , Fluoroquinolonas/farmacocinética , Animais , Anti-Infecciosos/química , Anti-Infecciosos/farmacocinética , Ciprofloxacina/química , Ciprofloxacina/metabolismo , Ciprofloxacina/farmacocinética , Resíduos de Drogas/metabolismo , Enrofloxacina , Feminino , Fluoroquinolonas/metabolismoRESUMO
Iragüen, D., Urcelay, S., San Martín, B. Pharmacovigilance in veterinary medicine in Chile: a pilot study. J. vet. Pharmacol. Therap.34, 108-115. In Chile, there is no present government policy to survey and analyse adverse drug reactions (ADRs) in the field of veterinary medicine. The intent of this study is to assess, for the first time, ADR frequency in treated animals. To this purpose, a 6-month period pilot study based on WHO recommendations was conducted to monitor ADRs in cats and dogs for frequently used drugs and common labelled signs. Of a total of 149 detected ADRs, 29 (6 in cats and 23 in dogs) were notified by means of ADR report forms, while the rest was identified after reviewing patient clinical records, thus evidencing strong under-reporting problems. More than 70% of ADRs were related to antimicrobials, vaccines and tranquilizers. In dogs, there was a significant effect on ADRs' presentation when acepromazine, amoxicillin, carprofen, ivermectin, sextuple vaccine (polyvalent vaccine that confers immunity against canine distemper virus, canine parvovirus, Leptospira canicola, L. icterohemmoragiae, canine adenovirus type 2 and canine parainfluenza virus) and phytomenadione (subcutaneous injection) were administered. In the case of cats, a significant influence on ADRs was detected when acepromazine, amoxicillin or vitamin K was administered. Present results suggest the need for a pharmacovigilance programme in veterinary medicine for timely ADR-presenting drug detection and drug safety improvement.
Assuntos
Sistemas de Notificação de Reações Adversas a Medicamentos , Drogas Veterinárias/efeitos adversos , Medicina Veterinária/normas , Animais , Antibacterianos/efeitos adversos , Doenças do Gato/induzido quimicamente , Doenças do Gato/tratamento farmacológico , Gatos , Chile , Doenças do Cão/induzido quimicamente , Doenças do Cão/tratamento farmacológico , Cães , Projetos Piloto , Vigilância de Produtos Comercializados , Tranquilizantes/efeitos adversos , Vacinas/efeitos adversosRESUMO
To ensure the delivery of safe animal products to consumers, withdrawal times (WDT) of drugs must be respected. Drugs administered in therapies can also reach nonedible tissues (for humans) such as feathers; this transfer is of concern as feather meal is used in diets of food producing animals, being this a possible source of residue contamination of final products for human consumption. WDTs of three flumequine formulations (10%, 80% premix powder and 20% solution) as well as the transfer of this drug into feathers were determined. One hundred and twenty broiler chickens were allocated into four experimental groups (36 birds each). Three of them were treated with 24 mg/kg bw orally for five consecutive days of each flumequine formulation, whereas one group remained untreated (12 birds as control group). After the treatment ended, six chickens of each experimental group and two controls were slaughtered daily for 6 days. Samples of muscle, liver and feathers were collected and analyzed by liquid chromatography tandem mass spectrometry (LC MS/MS). The WDTs showed differences between formulations. Flumequine concentrations found in feathers remained high during WDT and after this period, thus suggesting that the WDTs estimated for the pharmaceutical formulation of flumequine do not guarantee the absence of this drug in chicken nonedible tissues such as feathers.
Assuntos
Anti-Infecciosos/farmacocinética , Galinhas/metabolismo , Resíduos de Drogas/análise , Plumas/química , Fluoroquinolonas/farmacocinética , Administração Oral , Animais , Anti-Infecciosos/administração & dosagem , Relação Dose-Resposta a Droga , Plumas/metabolismo , Fluoroquinolonas/administração & dosagem , Fígado/química , Fígado/metabolismo , Masculino , Músculo Esquelético/química , Músculo Esquelético/metabolismo , Distribuição Aleatória , Distribuição TecidualRESUMO
To ensure delivery of safe animal products to consumers, the withdrawal time (WDT) of drugs must be respected. Property differences among pharmaceutical formulations, for the same drugs, can lead to differences in the WDTs estimation. The WDTs of four commercial formulations of enrofloxacin (ENRO) in broiler chickens, considering MRLs established by different countries, were studied. Two hundred-thirty-four broiler chicks were allotted among four groups; the formulations were orally administered daily with 10 mg/kg bw. After treatment, six chickens of each group and two controls were slaughtered daily until day 9 post-treatment. Samples of muscle and liver were collected, and analyzed using HPLC-MS-MS. The WDTs among formulations of ENRO showed differences of 24 and 48 h. Based on the European Community and Chile MRLs of 100 microg/kg (muscle) and 200 microg/kg (liver), the WDTs did not exceed 5 days. When Japan MRL was considered (10 microg/kg(,)), the WDTs increased up to 8 days. These results indicate that for WDTs determination, the differences among pharmaceutical formulations of a drug must be considered as well as the MRLs.
Assuntos
Antibacterianos/farmacocinética , Resíduos de Drogas/farmacocinética , Fluoroquinolonas/farmacocinética , Animais , Antibacterianos/administração & dosagem , Antibacterianos/análise , Galinhas/metabolismo , Cromatografia Líquida de Alta Pressão/veterinária , Rotulagem de Medicamentos/normas , Resíduos de Drogas/análise , Enrofloxacina , Fluoroquinolonas/administração & dosagem , Fluoroquinolonas/análise , Contaminação de Alimentos/prevenção & controle , Masculino , Espectrometria de Massas/veterinária , Músculo Esquelético/química , Fatores de TempoRESUMO
To ensure delivery of safe foods to consumers, withdrawal times for drugs must be respected according to the maximum residual limits established by regulatory agencies. Because of availability and price, feather meal is currently incorporated into animal feed as a protein source for farm species. Few data are available on residual drugs in feathers from treated animals. A depletion study was performed with laying hens treated intramuscularly with 5% enrofloxacin (Enromic) at 10 mg/kg body weight over 3 days. Thirty-three birds were treated and slaughtered at different times between 6 and 216 h after treatment; and samples of muscle plus skin, liver, kidney, and feathers were collected. High-performance liquid chromatography coupled with a tandem mass spectrometry method was validated before sample analysis to determine the decision limit, detection capability, recovery, and precision. Liver was the edible tissue with the slowest drug depletion. A withdrawal time of 6 days was calculated based on European Union maximum residual limits (100 microg/kg). A withdrawal time of 9 days was calculated based on Japan maximum residual limits (10 microg/kg). Enrofloxacin plus ciprofloxacin concentrations in feathers remained high through all sampling periods. Thus, feathers from treated animals should not be fed to food-producing animals.
Assuntos
Antibacterianos/farmacocinética , Galinhas/metabolismo , Resíduos de Drogas/análise , Plumas/química , Fluoroquinolonas/farmacocinética , Animais , Cromatografia Líquida de Alta Pressão/métodos , Ciprofloxacina/metabolismo , Ciprofloxacina/farmacocinética , Qualidade de Produtos para o Consumidor , Enrofloxacina , Feminino , Humanos , Espectrometria de Massas em Tandem/métodos , Fatores de TempoRESUMO
Echinococcus granulosus is a parasitic cestode causing hydatidosis in intermediate hosts (human and herbivorous). Most symptoms of the disease occur by the pressure exerted on viscera by cysts that are formed upon ingestion of the parasite eggs excreted by definitive hosts (canines). Protoscoleces, the developmental form of the parasite infective to definitive hosts, are formed in the germinal nucleated layer of fertile hydatid cysts. For unknown reasons, some cysts are unable to produce protoscoleces (infertile hydatid cysts). In this study, analysis of DNA fragmentation using TUNEL and agarose gel electrophoresis showed higher levels of apoptosis in infertile cysts as compared to fertile cysts. Additionally, caspase 3 was detected both in fertile and infertile cysts; the activity of this enzyme was found to be higher in infertile cysts. We conclude that apoptosis may be involved in hydatid cyst infertility. This is the first report on the presence of programmed cell death in E. granulosus.
Assuntos
Apoptose , Equinococose Hepática/metabolismo , Equinococose Pulmonar/metabolismo , Echinococcus granulosus/fisiologia , Infertilidade , Animais , Caspase 3/metabolismo , Bovinos , Equinococose Hepática/parasitologia , Equinococose Pulmonar/parasitologia , Echinococcus granulosus/isolamento & purificação , Marcação In Situ das Extremidades CortadasRESUMO
Time-related concentrations in milk of a combination of trimethoprim-sulphadiazine (TMP-SDZ) intramammary formulated infusion and its relationship with pathogenic bacteria strains minimum inhibitory concentrations (MICs) isolated from clinical mastitis cows were analysed. The MICs study was performed for Escherichia coli, Staphylococcus aureus and Streptococcus sp. strains. The SDZ concentrations in milk were analysed using high-performance liquid chromatography (HPLC) and TMP using a microbiological assay. Ten lactating cows milked three times daily were used in the time-concentration studies of TMP-SDZ. Milk samples (approximately 20 mL) from the treated mammary quarters were taken at 6, 12, 24, 30 and 36 h after first administration. In order to define the withdrawal time, milk samples from the treated mammary quarters were taken at 24, 36, 48, 72, 84 and 96 h, after finishing the therapy. The MICs fluctuated between 1 and 8 microg/mL. Effective therapeutic concentrations lasted for 36 h when intramammary infusion was repeated three times every 12 h. No TMP was detected in milk for 24 h after finishing therapy. Milk SDZ concentrations were below 0.1 microg/mL in all treated cows after 84 h finishing therapy. At 96 h after finishing therapy, no SDZ milk concentrations were found in six animals, although four animals of the experimental group still had concentrations of 0.07 microg/mL.